Learn about the global biologics market through The Business Research Company, which provides information on biologics market size, biologics market drivers and restraints, biologics market players, the COVID-19 impact on the biologics market, and more.

The global biologics market reached a value of nearly $253,414.8 million in 2020, having increased at a compound annual growth rate (CAGR) of 8.7% since 2015. The market is expected to grow from $253,414.8 million in 2020 to $420,551.5 million in 2025 at a rate of 10.7%. The market is then expected to grow at a CAGR of 9.6% from 2025 and reach $664,744.2 million in 2030.

Going forward increase in funding, technological advancements, increase in healthcare access, robust research and development activities for development of oral biologics, lean towards pills over injections, and increasing robust pipeline of biologics will drive the growth.

Request A Sample For The Global Biologics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=792&type=smph

The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics or biosimilars to treat and prevent various microbial diseases and cancers. The biologics market comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics.

Global Biologics Market Segments Include:

By Type- Therapeutic Proteins, Monoclonal Antibodies (MAbS), Vaccines

By Route Of Administration – Oral, Others (IV and IP) 

By Drug Classification – Branded Drugs, Generic Drugs

By Mode Of Purchase – Prescription Drugs, Over-The-Counter (OTC) Drugs 

By Distribution Channel – Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the global biologics market, accounting for 53.2% of the total in 2020.

Companies in the biologics market are generating high profit margins due to high prices of biologics and their effectiveness.

TBRC’s biologics market report covers:

Major Market Players: Merck & Co., Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson,

Pfizer Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Biologics Global Market Report 2022: Opportunities And Strategies – Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provides biologics market overviews, analyses and forecasts market size, share, biologics market players, biologics market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s biologics market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:  

Pharmaceutical Drugs Market

Orthobiologics Devices And Equipment Global Market Report 2021

Oral Biologics & Biosimilar Drugs Global Market Report 2021

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: